Analysis of Biomarkers for Congenital Heart Disease Based on Maternal Amniotic Fluid Metabolomics

Congenital heart disease (CHD) is the most common birth defect. The prenatal diagnosis of fetal CHD is completely dependent on ultrasound testing, but only ~40% of CHD can be detected. The purpose of this study is to find good biomarkers in amniotic fluid (AF) to detect CHD in the second trimester,...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Yahong, Sun, Yun, Yang, Lan, Huang, Mingtao, Zhang, Xiaojuan, Wang, Xin, Guan, Xianwei, Yang, Peiying, Wang, Yan, Meng, Lulu, Zhou, Ran, Zhou, Xiaoyan, Luo, Chunyu, Hu, Ping, Jiang, Tao, Xu, Zhengfeng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Cardiovascular Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8215886/
https://www.ncbi.nlm.nih.gov/pubmed/34164441
http://dx.doi.org/10.3389/fcvm.2021.671191

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8215886/
https://www.ncbi.nlm.nih.gov/pubmed/34164441
http://dx.doi.org/10.3389/fcvm.2021.671191

Ejemplares similares